Identifying Modifiable Risk Factors for Relapse in Patients With Schizophrenia in China
- PMID: 33061925
- PMCID: PMC7518216
- DOI: 10.3389/fpsyt.2020.574763
Identifying Modifiable Risk Factors for Relapse in Patients With Schizophrenia in China
Abstract
Background: Preventing relapse of schizophrenic patients is really a challenge. The present study sought to provide more explicit evidence and factors of different grades and weights by a series of step-by-step analysis through χ2 test, logistic regression analysis and decision-tree model. The results of this study may contribute to controlling relapse of schizophrenic patients.
Methods: A total of 1,487 schizophrenia patients were included who were 18-65 years of age and discharged from 10 hospitals in China from January 2009 to August 2009 and from September 2011 to February 2012 with improvements or recovery of treatment effect. We used a questionnaire to collect information about relapse and correlative factors during one year after discharge by medical record collection and telephone interview. The χ2 test and logistic regression analysis were used to identify risk factors and high-risk factors firstly, and then a decision-tree model was used to find predictive factors.
Results: The χ2 test found nine risk factors which were associated with relapse. Logistic regression analysis also showed four high-risk factors further (medication adherence, occupational status, ability of daily living, payment method of medical costs). At last, a decision-tree model revealed four predictors of relapse; it showed that medication adherence was the first grade and the most powerful predictor of relapse (relapse rate for adherence vs. nonadherence: 22.9 vs. 55.7%, χ2 = 116.36, p < 0.001). The second grade factor was occupational status (employment vs. unemployment: 19.7 vs. 42.7%, χ2 = 17.72, p < 0.001); the third grade factors were ability of daily living (normal vs. difficult: 28.4 vs. 54.3%, χ2 = 8.61, p = 0.010) and household income (household income ≥ 3000 RMB vs. <3000 RMB: 28.6 vs. 42.4%, χ2 = 6.30, p = 0.036). The overall positive predictive value (PPV) of the logistic regression was 0.740, and the decision-tree model was 0.726. Both models were reliable.
Conclusions: For schizophrenic patients discharged from hospital, who had good medication adherence, more higher household income, be employed and normal ability of daily living, would be less likely to relapse. Decision tree provides a new path for doctors to find the schizophrenic inpatient's relapse risk and give them reasonable treatment suggestions after discharge.
Keywords: decision-tree model; predictors; relapse; risk factors; schizophrenia.
Copyright © 2020 Mi, Chen, Fan, Tabarak, Xiao, Cao, Li, Bao, Han, Li, Shi, Guo, Wang, Liu, Wang, Chen, Wu, Ma, Li, Xiao, Liu, Xie, Zhang and Lu.
Figures
Similar articles
-
High relapse rate and poor medication adherence in the Chinese population with schizophrenia: results from an observational survey in the People's Republic of China.Neuropsychiatr Dis Treat. 2015 May 8;11:1161-7. doi: 10.2147/NDT.S72367. eCollection 2015. Neuropsychiatr Dis Treat. 2015. PMID: 26056450 Free PMC article.
-
Choices of medical institutions and associated factors in older patients with multimorbidity in stabilization period in China: A study based on logistic regression and decision tree model.Health Care Sci. 2023 Oct 16;2(6):359-369. doi: 10.1002/hcs2.73. eCollection 2023 Dec. Health Care Sci. 2023. PMID: 38938623 Free PMC article.
-
Predictors of relapse in the year after hospital discharge among patients with schizophrenia.Psychiatr Serv. 2012 Jan;63(1):87-90. doi: 10.1176/appi.ps.201100084. Psychiatr Serv. 2012. PMID: 22227766
-
[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].Encephale. 2005 Mar-Apr;31(2):235-46. doi: 10.1016/s0013-7006(05)82390-5. Encephale. 2005. PMID: 15959450 Review. French.
-
Medication Adherence Decisions in Patients With Schizophrenia.Prim Care Companion CNS Disord. 2017 Dec 7;19(6):17n02182. doi: 10.4088/PCC.17n02182. Prim Care Companion CNS Disord. 2017. PMID: 29216418 Review.
Cited by
-
Relapse rate and predictors among people with severe mental illnesses at Debre Markos Comprehensive specialized hospital, Northwest Ethiopia: a prospective follow up study.Eur Arch Psychiatry Clin Neurosci. 2024 Sep 18. doi: 10.1007/s00406-024-01900-1. Online ahead of print. Eur Arch Psychiatry Clin Neurosci. 2024. PMID: 39292261
-
Digital health interventions to improve adherence to oral antipsychotics among patients with schizophrenia: a scoping review.BMJ Open. 2023 Nov 17;13(11):e071984. doi: 10.1136/bmjopen-2023-071984. BMJ Open. 2023. PMID: 37977861 Free PMC article.
-
The impact of the COVID-19 pandemic and earthquake on mental health of persons with severe mental illness: A survey study among people receiving community mental health care versus treatment as usual in Croatia.Int J Soc Psychiatry. 2023 May;69(3):653-663. doi: 10.1177/00207640221130966. Epub 2022 Nov 1. Int J Soc Psychiatry. 2023. PMID: 36317586 Free PMC article.
-
Risk Factors for Relapse in People with Severe Mental Disorders during the COVID-19 Pandemic: A Multicenter Retrospective Study.Healthcare (Basel). 2021 Dec 30;10(1):64. doi: 10.3390/healthcare10010064. Healthcare (Basel). 2021. PMID: 35052228 Free PMC article.
-
Shanghai Community-Based Schizophrenia Cohort (SCS): a protocol for establishing a longitudinal cohort and research database of patients with schizophrenia receiving community-based mental health treatment.BMJ Open. 2024 Apr 9;14(4):e079312. doi: 10.1136/bmjopen-2023-079312. BMJ Open. 2024. PMID: 38594189 Free PMC article.
References
-
- Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, et al. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry (2004) 161(2 Suppl):1–56. - PubMed
-
- Linszen DH, Dingemans P, Scholte WF, Lenior ME, Goldstein MJ. Early recognition, internsive intervention and other protective and risk factors for psychotic relapse in patients with first psychotic episodes in schizophrenia. Int Clin Psychopharmacol (1998) 13(1):S7–S12. 10.1097/00004850-199801001-00003 - DOI
LinkOut - more resources
Full Text Sources